PSP Research »

Intellia Therapeutics shares owned by PSP Research

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $345k 27k 12.82

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
BlackRock
State Street Corporation
D. E. Shaw & Co
Regeneron Pharmaceuticals
Two Sigma Investments
Geode Capital Management
Two Sigma Advisers
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Dimensional Fund Advisors
Susquehanna International
FMR

View all funds holding Intellia Therapeutics